Blood transfusions in athletes. Old dogmas, new tricks

Abstract Blood doping consists of any illicit means used to increase and optimize oxygen delivery to the muscles and includes blood transfusions, administration of erythropoiesis-stimulating substances, blood substitutes, natural or artificial altitude facilities, and innovative gene therapies. The use of blood transfusion, an extremely straightforward, practical and effective means of increasing an athlete's red blood-cell supply in advance of competition, became rather popular in the 1970s, but it has suddenly declined following the widespread use of recombinant human erythropoietin among elite endurance athletes. Most recently, following implementation of reliable tests to screen for erythropoiesis-stimulating substances, blood transfusions have made a strong resurgence, as attested by several positive doping tests. Doping by blood transfusion can be classified as homologous, where the blood is infused into someone other than the donor, and autologous, where the blood donor and transfusion recipient are the same. The former case produces more clinically relevant side effects, but is easily detectable using current antidoping protocols based on erythrocyte phenotyping by flow cytometry and, eventually, erythrocyte genotyping by DNA testing. Since the donor and recipient blood are identical in autologous blood doping, this is less risky, though much more challenging to detect. Indirect strategies, relying on significant deviations from individual hematological profiles following autologous blood donation and reinfusion, are currently being investigated. For the time being, the storage of athletes' blood samples to allow testing and sanctioning of guilty athletes once a definitive test has been introduced may represent a reliable deterrent policy. Clin Chem Lab Med 2006;44:1395–402.

[1]  S. Harridge,et al.  Gene doping. , 2008, Essays in biochemistry.

[2]  Mario Plebani,et al.  Managing transferability of laboratory data. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[3]  G. Lippi,et al.  Preanalytical variability: the dark side of the moon in laboratory testing / Präanalytische Variabilität: die Schattenseite klinischer Laboruntersuchungen , 2006, Clinical chemistry and laboratory medicine.

[4]  L. Avois,et al.  Erythropoietin and blood doping , 2006, British Journal of Sports Medicine.

[5]  G. Banfi,et al.  Haematological parameters in elite rugby players during a competitive season. , 2006, Clinical and laboratory haematology.

[6]  G Lippi,et al.  The influence of the tourniquet time on hematological testing for antidoping purposes. , 2006, International journal of sports medicine.

[7]  A. Montpetit,et al.  High‐throughput molecular profiling of blood donors for minor red blood cell and platelet antigens , 2006, Transfusion.

[8]  G. Banfi,et al.  Reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, and mean sphered cell volume in elite athletes: reference values and comparison with the general population , 2006, Clinical chemistry and laboratory medicine.

[9]  G. Lippi,et al.  Preanalytical variability: the dark side of the moon in laboratory testing , 2006, Clinical chemistry and laboratory medicine.

[10]  G. Lippi,et al.  Biochemistry, Physiology, and Complications of Blood Doping: Facts and Speculation , 2006, Critical reviews in clinical laboratory sciences.

[11]  Ken Sharpe,et al.  A third generation approach to detect erythropoietin abuse in athletes. , 2006, Haematologica.

[12]  G. Csako,et al.  Rapid and/or high-throughput genotyping for human red blood cell, platelet and leukocyte antigens, and forensic applications. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[13]  S. Mortensen,et al.  Effects of blood withdrawal and reinfusion on biomarkers of erythropoiesis in humans: Implications for anti-doping strategies. , 2006, Haematologica.

[14]  G. Lippi,et al.  Phlebotomy issues and quality improvement in results of laboratory testing. , 2006, Clinical Laboratory.

[15]  G. Lippi,et al.  Stability of blood cell counts, hematologic parameters and reticulocytes indexes on the Advia A120 hematologic analyzer. , 2005, The Journal of laboratory and clinical medicine.

[16]  G. Lippi,et al.  Haematological testing and antidoping policies - Re: Robinson N, Schattenberg L, Zorzoli M, Mangin P, Saugy M. Haematological analysis conducted at the departure of the Tour de France 2001. Int J Sports Med 2005; 26: 200-207. , 2005, International journal of sports medicine.

[17]  C. Alfrey,et al.  The Negative Regulation of Red Cell Mass by Neocytolysis: Physiologic and Pathophysiologic Manifestations , 2005, Cellular Physiology and Biochemistry.

[18]  J. D. den Dunnen,et al.  Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization , 2005, Transfusion.

[19]  Michael Seul,et al.  A flexible array format for large‐scale, rapid blood group DNA typing , 2005, Transfusion.

[20]  G. Denomme,et al.  High‐throughput multiplex single‐nucleotide polymorphism analysis for red cell and platelet antigen genotypes , 2005, Transfusion.

[21]  W. Mayr,et al.  Tetragametic chimerism detected in a healthy woman with mixed‐field agglutination reactions in ABO blood grouping , 2005, Transfusion.

[22]  R. Ventura,et al.  Hematologic response to four weeks of intermittent hypobaric hypoxia in highly trained athletes. , 2005, Haematologica.

[23]  P. McCrory.  Pursuing the dream , 2004, British Journal of Sports Medicine.

[24]  Ken Sharpe,et al.  Standardization of reticulocyte values in an antidoping context. , 2004, American journal of clinical pathology.

[25]  S. Leigh-Smith.  Blood boosting , 2004, British Journal of Sports Medicine.

[26]  E. B. Pedersen,et al.  Hypochromic reticulocytes, hypochromic erythrocytes and p-transferrin receptors in diagnosing iron-deficient erythropoiesis , 2004, Scandinavian journal of clinical and laboratory investigation.

[27]  M. Audran,et al.  Longitudinal variation of hemoglobin and reticulocytes in elite rowers. , 2004, Haematologica.

[28]  Yorck Olaf Schumacher,et al.  Effect of pre-competition and altitude training on blood models used to detect erythropoietin abuse by athletes. , 2004, Haematologica.

[29]  Giuseppe Lippi,et al.  Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive? , 2004, Haematologica.

[30]  G. Banfi,et al.  Preanalytical phase of sport biochemistry and haematology. , 2003, The Journal of sports medicine and physical fitness.

[31]  G. Banfi,et al.  Comparison of 3 automatic systems for reticulocytes counts during an ultraendurance mountain marathon. , 2003, The Journal of sports medicine and physical fitness.

[32]  T. Videman,et al.  Abnormal Hematologic Profiles in Elite Cross-Country Skiers: Blood Doping or? , 2003, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[33]  Hongbo Yu,et al.  Risks of blood transfusion and their prevention. , 2003, Clinical advances in hematology & oncology : H&O.

[34]  H. Prendergast,et al.  The toxic torch of the modern Olympic Games. , 2003, Veterinary and human toxicology.

[35]  Luca Malcovati,et al.  Hematologic passport for athletes competing in endurance sports: a feasibility study. , 2003, Haematologica.

[36]  M. Ashenden,et al.  Proof of homologous blood transfusion through quantification of blood group antigens. , 2003, Haematologica.

[37]  J. Gauthier.  [Blood doping and cardiovascular consequences]. , 2002, Presse medicale.

[38]  A. Berg,et al.  Hematological indices in elite cyclists , 2002 .

[39]  G Lippi,et al.  Haematocrit measurement and antidoping policies. , 2002, Clinical and laboratory haematology.

[40]  G. Zini,et al.  Addendum to strategies to deter blood doping in sports. , 2002, Haematologica.

[41]  M. Ashenden,et al.  Detection of homologous blood transfusion by flow cytometry: a deterrent against blood doping. , 2002, Haematologica.

[42]  Björn Ekblom,et al.  Dopning inom uthållighetsidrotter [Doping in endurance sports] : Kartläggning av individuell [Hb]-nivå kan avslöja dopning , 2001 .

[43]  J. Spivak,et al.  Erythropoietin use and abuse: When physiology and pharmacology collide. , 2001, Advances in experimental medicine and biology.

[44]  H. Holmberg,et al.  [Doping in endurance sports. Survey of individual [Hb] levels can expose doping]. , 2001, Lakartidningen.

[45]  C. D. de Souza,et al.  Blood group genotyping in a population of highly diverse ancestry , 2001, Journal of clinical laboratory analysis.

[46]  J. Spivak.  Erythropoietin use and abuse: When physiology and pharmacology collide. , 2001, Advances in experimental medicine and biology.

[47]  J Keul,et al.  Haemoglobin, Haematocrit and Red Blood Cell Indices in Elite Cyclists. Are the Control Values for Blood Testing Valid? , 2000, International journal of sports medicine.

[48]  B. Ekblom.  Blood boosting and sport. , 2000, Bailliere's best practice & research. Clinical endocrinology & metabolism.

[49]  N. Avent,et al.  The Rh blood group system: a review. , 2000, Blood.

[50]  C J Gore,et al.  A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. , 2000, Haematologica.

[51]  Gassner,et al.  Rh phenotype prediction by DNA typing and its application to practice , 1998, Transfusion medicine.

[52]  D. S. James,et al.  A randomized, double‐blind comparison of donor tolerance of 400 mL, 200 mL, and sham red cell donation , 1996, Transfusion.

[53]  N. A. Ghaphery.  Performance-enhancing drugs. , 1995, The Orthopedic clinics of North America.

[54]  J. Cartron.  Defining the Rh blood group antigens. Biochemistry and molecular genetics. , 1994, Blood reviews.

[55]  Daniel A. Smith,et al.  The Efficacy of Ergogenic Agents in Athletic Competition: Part II: Other Performance-Enhancing Agents , 1992, The Annals of pharmacotherapy.

[56]  Daniel A. Smith,et al.  The Efficacy of Ergogenic Agents in Athletic Competition Part I: Androgenic-Anabolic Steroids , 1992, The Annals of pharmacotherapy.

[57]  G. Birgegard,et al.  Effects of blood transfusions on some hematological variables in endurance athletes. , 1989, Medicine and science in sports and exercise.

[58]  R. Macwalter,et al.  Biologic variation of common hematologic laboratory quantities in the elderly. , 1989, American journal of clinical pathology.

[59]  D. T. Tunstall Pedoe,et al.  Blood doping--a literature review. , 1989, British journal of sports medicine.

[60]  B. Berglund,et al.  Effect of reinfusion of autologous blood on exercise performance in cross-country skiers. , 1987, International journal of sports medicine.

[61]  T. Simon,et al.  The effects of red blood cell infusion on 10-km race time. , 1987, JAMA.

[62]  G. Birgegard,et al.  Detection of Autologous Blood Transfusions in Cross-Country Skiers , 1987, International journal of sports medicine.

[63]  N. Gledhill,et al.  Effect of graded erythrocythemia on cardiovascular and metabolic responses to exercise. , 1986, Journal of applied physiology.

[64]  H. Klein.  Blood transfusion and athletics. Games people play. , 1985, The New England journal of medicine.

[65]  P. Brombacher,et al.  Short-Term and Long-Term Intra-Individual Variations and Critical Differences of Haematological Laboratory Parameters , 1985 .

[66]  P. Brombacher,et al.  Short-Term and Long-Term Intra-Individual Variations and Critical Differences of Haematological Laboratory Parameters , 1985, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[67]  G. Skrinar,et al.  Effect of induced erythrocythemia on hypoxia tolerance during physical exercise. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[68]  J. Lee,et al.  Electrical properties of lightly doped polycrystalline silicon , 1982 .

[69]  M. H. Williams,et al.  The effect of induced erythrocythemia upon 5-mile treadmill run time. , 1981, Medicine and science in sports and exercise.

[70]  N. Gledhill,et al.  Effect of induced erythrocythemia on aerobic work capacity. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.

[71]  B. Ekblom,et al.  Response to exercise after blood loss and reinfusion. , 1972, Journal of applied physiology.